VIP stimulation of cAMP production in corneal endothelial cells in tissue and organ cultures

Cornea

Volumn 21, Issue 3, 2002, Pages 270-274

  Koh, Shay Whey M ^a,c   Yue, Beatrice Y J T ^b  

^a UNIVERSITY OF MARYLAND   (United States)

^b UNIVERSITY OF ILLINOIS   (United States)

^c NONE   (United States)

Author keywords

Cell culture; Corneal endothelium; Corneal organ culture; Cyclic AMP; Vasoactive intestinal peptide

Indexed keywords

ALPHA INTERMEDIN; CYCLIC AMP; GLUCAGON; IMMUNOSUPPRESSIVE AGENT; ISOPRENALINE; PROSTAGLANDIN E1; VASOACTIVE INTESTINAL POLYPEPTIDE;

AGED; ANIMAL CELL; ANIMAL TISSUE; AQUEOUS HUMOR; ARTICLE; CATTLE; CELL CULTURE; CELL STIMULATION; CONTROLLED STUDY; CORNEA ENDOTHELIUM; DOSE TIME EFFECT RELATION; HUMAN; HUMAN CELL; NONHUMAN; ORGAN CULTURE; PRIORITY JOURNAL; RABBIT; RADIOIMMUNOASSAY; TISSUE CULTURE;

AGED; ANIMALS; CATTLE; CELL CULTURE TECHNIQUES; CYCLIC AMP; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, CORNEAL; HUMANS; ORGAN CULTURE TECHNIQUES; RABBITS; TIME FACTORS; VASOACTIVE INTESTINAL PEPTIDE;

EID: 0036198361     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003226-200204000-00007     Document Type: Article

References (50)

1. Vasoactive intestinal peptide stimulation of human trabecular meshwork cell growth
2. VIP stimulates proliferation and differentiation of the cultured retinal pigment epithelium with disparate potencies
3. Vasoactive intestinal peptide regulates mitosis, differentiation and survival of cultured sympathetic neuroblasts
4. Neuropeptides as growth and differentiation factors in general and VIP in particular
5. Vasoactive intestinal peptide enhancement of antigen-induced differentiation of a cultured line of mouse thymocytes
6. Vasoactive intestinal peptide is a neuropeptide mediator of the secretory response to serotonin in rat
7. Transcellular fluid secretion induced by cholera toxin and vasoactive intestinal polypeptide in the small intestine of the rat
8. Effects of delta9-THC on VIP-induced prolactin secretion in anterior pituitary cultures: Evidence for the presence of functional cannabinoid CB1 receptors in pituitary cells
9. Rat and guinea pig pancreatic acini possess both VIP(1) and VIP(2) receptors, which mediate enzyme secretion
10. VIP stimulation of polarized macromolecule secretion in cultured chick embryonic retinal pigment epithelium
11. Immunolocalization of muscarinic and VIP receptor subtypes and their role in stimulating goblet cell secretion
12. Control of porcine lacrimal gland secretion by non-cholinergic, non-adrenergic nerves: Effects of electrical field stimulation, VIP and NPY
13. Quantitation of rat lacrimal secretion: A novel sandwich ELISA with high sensitivity
14. Vasoactive intestinal peptide: A neurotrophic releasing agent and an astroglia mitogen
15. Neuroprotective strategy for Alzheimer disease: Intranasal administration of a fatty neuropeptide
16. Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide
17. Protective effects of vasoactive intestinal peptide against delayed glutamate neurotoxicity in cultured retina
18. Corneal endothelial cell survival in organ cultures under acute oxidative stress: Effect of VIP
19. Immunoreactive vasoactive intestinal peptide contributes to the immunosuppressive activity of normal aqueous humor
20. Ocular immune privilege and the Faustian dilemma
21. Effects of agonists on the intracellular cyclic AMP concentration in monkey trabecular meshwork cells
22. High affinity vasoactive intestinal peptide receptors on fetal human nonpigmented ciliary epithelial cells
23. Regulation of the vasoactive intestinal peptide receptor
24. International union of pharmacology. XVIII. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide
25. Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptide
26. The VIP2 receptors: Molecular characterization of a cDNA encoding a novel receptor for vasoactive intestinal peptide
27. Studies of corneas in vivo and in vitro
28. Growth of human CE cells in culture
29. Agonist effects on the intracellular cyclic AMP concentration of retinal pigment epithelium cells in culture
30. Protein measurement with Folin phenol reagent
31. The corneal endothelium: Normal and pathologic structure and function
32. The endothelial pump of the cornea
33. Protective effect of docosa-hexaenoic acid against hydrogen peroxide- induced oxidative stress in human lymphocytes
34. Constitutive hsp70 attenuates hydrogen peroxide-induced membrane lipid peroxidation
35. Effects of chloride channel inhibitors on H202-induced renal epithelial cell injury
36. Role of lipid peroxidation in H202-induced renal epithelial (LLC-PK1) cell injury
37. Adverse effects of oxidative stress on renal cells and its prevention by antioxidants
38. Disassociation of oxidant-induced ATP depletion and DNA damage from early cytotoxicity in LLC-PKI cells
39. Lazaroid compounds prevent early but not late stages of oxidant-induced cell injury: Potential explanation for the lack of efficacy of lazaroids in clinical trials
40. Cyclic nucleotides attenuate lipid peroxidation-mediated neuron toxicity
41. Corticotropin-releasing hormone protects neurons against insults relevant to the pathogenesis of Alzheimer's disease
42. Effect of adrenoreceptors on endotoxin-induced cytokines and lipid peroxidation in lung explants
43. Induction of apoptosis in cerebellar granule neurons by low potassium: Inhibition of death by insulin-like growth factor I and cAMP
44. The death program in cultured sympathetic neurons can be suppressed at the posttranslational level by nerve growth factor, cyclic AMP, and depolarization
45. Differential effects of cAMP in neurons and astrocytes
46. Cyclic AMP elevation is sufficient to promote the survival of spinal motor neurons in vitro
47. Neutralizing anti-p21 Ras Fabs suppress rat sympathetic neuron survival induced by NGF, LIF, CNTF and cAMP
48. Desensitization of beta-adrenergic receptors in corneal endothelium
49. Ultrastructural effects of topical Betoptic, Betagan, and Timoptic on the rabbit corneal endothelium
50. Prostaglandin E2 effects on CE cyclic adenosine monophosphate synthesis and cell shape are mediated by a receptor of the EP2 subtype